- Tuesday, 7 July 2020 |
- Today's FE |
- e-Paper
Hundreds of scientists say there is evidence that the novel...
The World Health Organization (WHO) said on Saturday that it...
The absence of a certain guideline and a policy on...
Almost 30 per cent of genome sequencing data from samples...
Altogether 1,000 scientists and researchers from all over the world...
Bangladesh is now 8th country in the world in weekly...
People testing negative for coronavirus antibodies may still have some...
A COVID-19 vaccine developed by German biotech firm BioNTech and...
Bharat Biotech’s Covid-19 vaccine has been approved for human trials,...
Chinese scientists have expressed concern after detecting another new strain...
The Covid-19 pandemic is not even close to being over,...
Healthcare officials and experts have said despite continued coronavirus onslaughts...
Gilead Sciences Inc said on Monday it has priced its...
Some 105 global leaders, including 18 Nobel Laureates, have signed...
China National Biotec Group said on Sunday that early human...
In the six months since an entirely new coronavirus began...
A global fundraising meeting on Saturday raised 6.15 billion euros...
Global coronavirus cases exceeded 10 million on Sunday according to...
Dr Gopi Patel recalls how powerless she felt when New...
A trial in pigs of AstraZeneca's experimental COVID-19 vaccine has found that two doses of the shot produced a greater antibody response than a single dose. Research released by Britain's Pirbright Institute on Tuesday found that giving an initial prime dose followed by a booster dose of the vaccine elicited...
© 2020 - All Rights with The Financial Express
